(Reuters) - Australian liver cancer treatment provider Sirtex Medical Ltd <SRX.AX> on Tuesday said it received a binding takeover offer from Chinese private equity firm CDH Investments.
CDH Investments this month made a last-minute offer of $1.4 billion, or A$33.60 per share, for Sirtex Medical, topping Varian Medical Systems <VAR.N> days before the U.S. firm was set to seal a takeover deal.
Sirtex would make a recommendation on which proposal it believed was in shareholders' best interests after it assessed the CDH offer, the company said in a statement.
In January, Varian offered to buy Sirtex Medical for A$28 per share.
(Reporting by Susan Mathew in Bengaluru; Editing by Clarence Fernandez)
